Home > Boards > US Listed > Biotechs > Akari Therapeutics (AKTX)

I would like to contact management directly. Do

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BrazenBull Member Profile
 
Followed By 124
Posts 8,111
Boards Moderated 4
Alias Born 11/14/12
160x600 placeholder
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/30/2020 4:53:14 PM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 3/26/2020 6:04:19 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/11/2020 4:31:21 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/4/2020 9:26:02 AM
Akari Therapeutics, Plc Announces Closing of $9.5 Million Private Placement GlobeNewswire Inc. - 3/4/2020 8:52:41 AM
Akari Therapeutics, Plc Announces Private Placement GlobeNewswire Inc. - 2/20/2020 5:34:32 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/20/2020 5:26:44 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:26:10 PM
Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (V... GlobeNewswire Inc. - 1/27/2020 8:58:52 AM
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study GlobeNewswire Inc. - 1/10/2020 9:30:09 AM
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transpla... GlobeNewswire Inc. - 12/23/2019 8:45:10 AM
Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Rela... GlobeNewswire Inc. - 12/2/2019 8:30:10 AM
Akari Therapeutics Reports Third Quarter 2019 Financial Results And Highlights Recent Clinical Progress GlobeNewswire Inc. - 11/4/2019 8:33:48 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/28/2019 6:01:19 AM
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 10/15/2019 5:24:28 PM
Securities Registration (ads, Immediate) (f-6ef) Edgar (US Regulatory) - 10/15/2019 5:09:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 7:08:47 AM
Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial R... GlobeNewswire Inc. - 10/14/2019 8:37:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2019 9:03:34 AM
Akari Therapeutics Announces Positive Phase II Clinical Data in Orphan Blistering Skin Disease Bullous Pemphigoid at the 28th... GlobeNewswire Inc. - 10/10/2019 8:45:02 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/4/2019 4:48:17 PM
Akari Therapeutics to Participate in Ladenburg Thalmann Healthcare Conference GlobeNewswire Inc. - 9/18/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/13/2019 8:17:32 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid GlobeNewswire Inc. - 9/13/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/10/2019 8:22:04 AM
BrazenBull   Thursday, 08/16/18 03:30:50 PM
Re: makingbiigdough post# 204
Post # of 482 
I would like to contact management directly. Do you have any idea there contact info?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist